| Drug Name |
Nalidixic acid |
| Drug ID |
BADD_D01521 |
| Description |
Nalidixic acid is a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA gyrase. |
| Indications and Usage |
For the treatment of urinary tract infections caused by susceptible gram-negative microorganisms, including the majority of E. Coli, Enterobacter species, Klebsiella species, and Proteus species. |
| Marketing Status |
approved; investigational |
| ATC Code |
J01MB02 |
| DrugBank ID |
DB00779
|
| KEGG ID |
D00183
|
| MeSH ID |
D009268
|
| PubChem ID |
4421
|
| TTD Drug ID |
D07JGT
|
| NDC Product Code |
Not Available |
| UNII |
3B91HWA56M
|
| Synonyms |
Nalidixic Acid | Acid, Nalidixic | Nalidixin | Nalidixate Sodium Anhydrous | Anhydrous, Nalidixate Sodium | Sodium Anhydrous, Nalidixate | Sodium Nalidixic Acid, Anhydrous | Nevigramon | Nalidixate Sodium | Sodium, Nalidixate | Sodium Nalidixic Acid, Monohydrate |
